Article > CHMP stuns Pfizer with rejection of RA drug Xeljanz

Un post di particolare interesse dal:

ra biologics – Google Blog Search:

Article > CHMP stuns Pfizer with rejection of RA drug Xeljanz

Many analysts believe it could be a game-changer given that biologics that have come on the market over the past ten years for RA – AbbVie's Humira (adalimumab), Amgen's Enbrel (etanercept) and Johnson & Johnson's …

Per questo post si ringrazia:

ra biologics – Google Blog Search

e vi invitiamo a continuare la lettura su:

Article > CHMP stuns Pfizer with rejection of RA drug Xeljanz

Article > CHMP stuns Pfizer with rejection of RA drug Xeljanz

Utilizzando il sito, accetti l'utilizzo dei cookie da parte nostra. maggiori informazioni

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close